LOGO
LOGO

Intraday Alerts

Arqit Quantum Rises 3% On Performance Highlights

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

Shares of Arqit Quantum Inc., (ARQQ), a U.K.-based quantum encryption technology company are up 3 percent following announcements of results of operational and financial performance for the first fiscal year ended 30 September, 2021.

Arqit that supplies quantum encryption Platform-as-a-Service had a full commercial launch immediately prior to 2021 fiscal year end and billings commenced only in Q4 of fiscal 2021. Arqit's Nasdaq listing was on 7 September 2021.

Post the commercial launch in September, the company has been able to sign contracts inter alia with BT Group, Sumitomo, Northrop Grumman, Dentons (London), Juniper Networks, Babcock, Blue Bear Systems Research Ltd and NEOM.

The company claims that the business momentum is in keeping with management expectations. For the fiscal year 2022, the company expects that the identified contract opportunities, both in terms of the number of opportunities and the cumulative dollar volume of opportunities, would continue to grow.

For the fiscal year, the company posted a loss before tax of $271.7 million and adjusted loss before tax of $15.6 million. It had cash and cash equivalents of $86.9 million.

Shares of Arqit Quantum are currently trading at $16.70, up $0.55 or 3.41 percent from the previous close.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

Latest Updates on COVID-19